来自德国的空肠弯曲菌分离株对环丙沙星、莫西沙星、红霉素、克林霉素和四环素的敏感性。
Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline.
作者信息
Wagner Jutta, Jabbusch Miriam, Eisenblätter Martin, Hahn Helmut, Wendt Constanze, Ignatius Ralf
机构信息
Department of Medical Microbiology and Immunology of Infection, Institute of Infectious Diseases Medicine, Benjamin Franklin Medical Center, Free University of Berlin, 12203 Berlin.
出版信息
Antimicrob Agents Chemother. 2003 Jul;47(7):2358-61. doi: 10.1128/AAC.47.7.2358-2361.2003.
Abstract
To elucidate Campylobacter jejuni resistance to antibiotics in Germany, MICs of ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline were determined (using agar dilution) for 144 clinical isolates. The data indicate a considerable ciprofloxacin resistance (45.1%) without a clonal relationship of the strains and a greater in vitro activity of moxifloxacin, erythromycin, and clindamycin.
摘要
为阐明德国空肠弯曲菌对抗生素的耐药性，采用琼脂稀释法测定了144株临床分离株对环丙沙星、莫西沙星、红霉素、克林霉素和四环素的最低抑菌浓度（MIC）。数据表明环丙沙星耐药情况较为严重（45.1%），且各菌株间无克隆关系，同时莫西沙星、红霉素和克林霉素的体外活性更强。
相似文献
1
Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline.
Antimicrob Agents Chemother. 2003 Jul;47(7):2358-61. doi: 10.1128/AAC.47.7.2358-2361.2003.
2
The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
J Antimicrob Chemother. 1999 May;43 Suppl B:25-9. doi: 10.1093/jac/43.suppl_2.25.
3
[Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method].
Epidemiol Mikrobiol Imunol. 2014 Sep;63(3):184-90.
4
Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli.
J Antimicrob Chemother. 1997 Jun;39(6):707-12. doi: 10.1093/jac/39.6.707.
5
In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001.
Antimicrob Agents Chemother. 2003 Sep;47(9):2946-50. doi: 10.1128/AAC.47.9.2946-2950.2003.
6
Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.
J Antimicrob Chemother. 1998 Dec;42(6):803-6. doi: 10.1093/jac/42.6.803.
7
Antimicrobial susceptibilities of Campylobacter strains isolated from Finnish subjects infected domestically or from those infected abroad.
Antimicrob Agents Chemother. 2003 Jan;47(1):102-5. doi: 10.1128/AAC.47.1.102-105.2003.
8
Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
Microb Drug Resist. 2001 Fall;7(3):257-61. doi: 10.1089/10766290152652800.
9
Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey.
J Med Microbiol. 2019 Feb;68(2):136-142. doi: 10.1099/jmm.0.000890. Epub 2018 Dec 12.
10
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
Int J Antimicrob Agents. 2002 Feb;19(2):111-8. doi: 10.1016/s0924-8579(01)00486-1.
引用本文的文献
1
Structural basis of DNA recognition of the CosR regulator.
mBio. 2024 Mar 13;15(3):e0343023. doi: 10.1128/mbio.03430-23. Epub 2024 Feb 7.
2
Prevalence, species diversity, and antimicrobial susceptibility of strains in patients with diarrhea and poultry meat samples: one-year prospective study.
Iran J Microbiol. 2022 Jun;14(3):362-372. doi: 10.18502/ijm.v14i3.9775.
3
Prevalence and antimicrobial susceptibility of species in human stool samples derived from out- and inpatients: the prospective German prevalence study Arcopath.
Gut Pathog. 2020 Apr 15;12:21. doi: 10.1186/s13099-020-00360-x. eCollection 2020.
4
A Historical Review on Antibiotic Resistance of Foodborne .
Front Microbiol. 2019 Jul 26;10:1509. doi: 10.3389/fmicb.2019.01509. eCollection 2019.
5
Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland.
Antimicrob Agents Chemother. 2007 Mar;51(3):1123-5. doi: 10.1128/AAC.01187-06. Epub 2007 Jan 8.
6
Antimicrobial susceptibilities of Campylobacter jejuni isolates from hospitalized children in Athens, Greece, collected during 2004-2005.
Eur J Epidemiol. 2007;22(1):77-8. doi: 10.1007/s10654-006-9080-3. Epub 2006 Dec 21.
7
Genetic relatedness and quinolone resistance of Campylobacter jejuni strains isolated in 2002 in Hong Kong.
J Clin Microbiol. 2004 Jul;42(7):3321-3. doi: 10.1128/JCM.42.7.3321-3323.2004.
本文引用的文献
1
Comparison of the Etest and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter.
J Antimicrob Chemother. 2002 Oct;50(4):487-94. doi: 10.1093/jac/dkf162.
2
Antimicrobial susceptibility patterns of Campylobacter jejuni strains isolated from hospitalized children in Athens, Greece.
J Antimicrob Chemother. 2002 May;49(5):803-5. doi: 10.1093/jac/dkf002.
3
Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones.
J Infect Dis. 2002 Mar 15;185(6):837-40. doi: 10.1086/339195. Epub 2002 Feb 8.
4
The stability of grlA, grlB, gyrA, gyrB and norA mutations and MIC values of five fluoroquinolones in three different clonal populations of methicillin-resistant Staphylococcus aureus.
Clin Microbiol Infect. 1999 May;5(5):287-290. doi: 10.1111/j.1469-0691.1999.tb00143.x.
5
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2001 Jun;45(6):1654-9. doi: 10.1128/AAC.45.6.1654-1659.2001.
6
In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis.
Int J Antimicrob Agents. 2001 Mar;17(3):229-31. doi: 10.1016/s0924-8579(00)00337-x.
7
Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona.
Antimicrob Agents Chemother. 2000 May;44(5):1140-5. doi: 10.1128/AAC.44.5.1140-1145.2000.
8
Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997.
J Clin Pathol. 1999 Nov;52(11):812-4. doi: 10.1136/jcp.52.11.812.
9
Resistance in Campylobacter species: increased resistance to fluoroquinolones and seasonal variation.
Clin Infect Dis. 1999 Oct;29(4):845-8. doi: 10.1086/520447.
10
Prevalence of Campylobacter spp. in poultry and poultry meat in Germany.
Int J Food Microbiol. 1999 Oct 15;51(2-3):187-90. doi: 10.1016/s0168-1605(99)00120-8.
Zotero 插件